EndoShape selected to present at Cavendish Global Health Impact Forum

284

EndoShape has announced that it has been selected to present at the Cavendish Global Health Impact Forum taking place 10–14 May in La Jolla, USA.

The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programmes within health and the life sciences. To accomplish this mission, the Forum showcases presentations and panel discussions by leading research institutions, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment.

The next Forum is being co-hosted by the community of La Jolla, California including The University of California San Diego, The J Craig Venter Institute, The Scripps Research Institute, The Sanford-Burnham Medical Research Institute, The Sanford Consortium for Regenerative Medicine, and The Institute of the Americas.

Michael Moffat, Cavendish co-founder and CEO explains, “The theme of our La Jolla, California Forum is a ‘celebration of philanthropy, impact investing and innovation that is changing the world.’ With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organisations that meet the required standard of excellence. The quality and originality of EndoShape’s research and scientific insights in polymer development and embolization technology positions them to make a major contribution to the treatment of many clinical indications including liver cancer, trauma, neurovascular conditions and pelvic congestion syndrome.”

“We are honoured to be selected to present at this unique event, and it is further recognition of our innovative approach to peripheral and neurovascular embolization” said Bill Aldrich, president and CEO, EndoShape. “We welcome the chance to interact with many of world’s most accomplished scientists, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world.”